HK Stock Market Move | TH MEDICAL-B(02697) rose 320% in the first half month after listing, reaching a new high. The State Council's "Twelfth Five-Year Plan" supports the development of innovative medical devices in the entire chain.

After breaking through 500 Hong Kong dollars yesterday, TH MEDICAL-B (02697) once again surged to a new high today. Intraday on July 14, the stock price reached 533.5 Hong Kong dollars, hitting a new record high since its listing. As of the time of writing, the stock price is at 530 Hong Kong dollars, up 10.69%, with a total market value close to 19 billion Hong Kong dollars. Calculated at the issuance price of 126.2 Hong Kong dollars, the cumulative increase in the half month since listing is close to 320%. On the news front, the State Council recently issued the "National Health '15th Five-Year Plan'", which clearly supports the development and application of innovative drugs and medical devices throughout the entire chain, streamlines the evaluation and approval of innovative drugs and urgently needed clinical drugs; increases support for the research and development of key core technologies, components, and complete machines of high-end medical devices; promotes the empowerment of artificial intelligence in the entire pharmaceutical industry chain; and improves the mechanism to support the high-quality development of innovative drugs and medical devices through medical insurance. The market believes that this policy systematically supports Innovative Medical Management instruments from the aspects of evaluation, research and development, clinical application, and medical insurance payment. As the domestic enterprise with the most approved number of puncture surgery Siasun Robot & Automation products, Zhenjian Health Medical's "brain-eye-hand" integrated technology route, and its product matrix from puncture navigation to microwave ablation, align well with the direction of high-end medical devices and artificial intelligence empowerment promoted by the policy. In addition, the scarcity of the Chinese percutaneous puncture surgery Siasun Robot & Automation market is further highlighted as it is still in the early stages of explosive growth.